These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7326239)

  • 21. Inhibition of DOPA decarboxylation by analogues of tryptophan.
    Bosin TR; Baldwin JR; Maickel RP
    Biochem Pharmacol; 1978; 27(8):1289-91. PubMed ID: 697928
    [No Abstract]   [Full Text] [Related]  

  • 22. Subunit structure of 3, 4-dihydroxyphenylalanine decarboxylase from pig kidney.
    Voltattorni CB; Minelli A; Cirotto C; Barra D; Turano C
    Arch Biochem Biophys; 1982 Aug; 217(1):58-64. PubMed ID: 7125679
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the inhibition of histidine decarboxylase, aromatic-L-amino acid decarboxylase and acid secretion by brocresine and its metabolites.
    Ellenbogen L; Kelly RG; Taylor RJ; Stubbs CS
    Biochem Pharmacol; 1973 Apr; 22(8):939-47. PubMed ID: 4693826
    [No Abstract]   [Full Text] [Related]  

  • 24. Substrate specificity and other properties of DOPA decarboxylase from guinea pig kidneys.
    Srinivasan K; Awapara J
    Biochim Biophys Acta; 1978 Oct; 526(2):597-604. PubMed ID: 309771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of the reaction of DOPA decarboxylase with 5-hydroxy-L-tryptophan.
    Salerno C; Borri Voltattorni C; Giartosio A; Fiori A; Turano C
    Prog Clin Biol Res; 1984; 144A():277-87. PubMed ID: 6610180
    [No Abstract]   [Full Text] [Related]  

  • 26. Green tea polyphenols: novel irreversible inhibitors of dopa decarboxylase.
    Bertoldi M; Gonsalvi M; Voltattorni CB
    Biochem Biophys Res Commun; 2001 Jun; 284(1):90-3. PubMed ID: 11374875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors binding to L-aromatic amino acid decarboxylase.
    Barboni E; Voltattorni CB; D'Erme M; Fiori A; Minelli A; Rosei MA
    Life Sci; 1982 Oct; 31(14):1519-24. PubMed ID: 6183555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A kinetic analysis of Drosophila melanogaster dopa decarboxylase.
    Black BC; Smarrelli J
    Biochim Biophys Acta; 1986 Mar; 870(1):31-40. PubMed ID: 3081033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of 3-(3,4-dihydroxyphenyl)alanine decarboxylase by 2-(fluoromethyl)-3-(3,4-dihydroxyphenyl)alanine.
    Maycock AL; Aster SD; Patchett AA
    Biochemistry; 1980 Feb; 19(4):709-18. PubMed ID: 7356954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatic amino acid decarboxylase: pH-dependence of substrates and inhibitors [proceedings].
    Bender DA; Coulson WF
    Biochem Soc Trans; 1977; 5(5):1353-6. PubMed ID: 21822
    [No Abstract]   [Full Text] [Related]  

  • 31. Purification and characterization of 3,4-dihydroxyphenylalanine decarboxyase from pig kidney.
    Voltattorni CB; Minelli A; Vecchini P; Fiori A; Turano C
    Eur J Biochem; 1979 Jan; 93(1):181-8. PubMed ID: 436828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine).
    Christenson JG; Dairman W; Udenfriend S
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):343-7. PubMed ID: 4536745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
    Bertoldi M; Borri Voltattorni C
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Action of some DOPA decarboxylase inhibitors with reference to different types of convulsions].
    HEROLD M; CAHN J; HELBECQUE C; KABACOFF O
    C R Seances Soc Biol Fil; 1962; 156():1273-6. PubMed ID: 13954030
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunohistochemical localization of aromatic L-amino acid decarboxylase (DOPA decarboxylase) in central dopamine and 5-hydroxytryptamine nerve cell bodies of the rat.
    Hökfelt T; Fuxe K; Goldstein M
    Brain Res; 1973 Apr; 53(1):175-80. PubMed ID: 4121370
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of 3,4-dihydroxy-L-phenylalanine decarboxylase in rat striatal synaptosomes by amino acids interacting with substrate transport.
    Katz IR
    Biochim Biophys Acta; 1980 Jul; 600(1):195-204. PubMed ID: 7397168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Purification and partial sequencing of L-dopa decarboxylase from pheochromocytoma in rats].
    Cogé F; Krieger-Poullet M; Guillemot JC; Ferrara P; Gros F; Thibault J
    C R Acad Sci III; 1989; 309(14):587-92. PubMed ID: 2510910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some immunochemical properties of pig kidney DOPA decarboxylase.
    Rosei MA; Citro G; D'Erme M; Finazzi-Agrò A
    Immunol Commun; 1984; 13(4):381-9. PubMed ID: 6434407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substrate specificity of aromatic-L-amino adid decarboxylase.
    Bosin TR; Buckpitt AR; Maickel RP
    Life Sci; 1974 Mar; 14(5):899-908. PubMed ID: 4828405
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
    Klawans HL; Ringel SP; Shenker DM
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):682-6. PubMed ID: 5158783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.